Market research
003520.KO Yungjin Pharm. Co., Ltd
KO KRW Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 217B
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.71
Community
Investor discussion
1 comment
Sign in to join the 003520.KO discussion.
5 years, 5 months ago
Yungjin Pharm. Co., Ltd is currently in a long term downtrend where the price is trading 13.1% below its 200 day moving average.
From a valuation standpoint, the stock is 38.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.3.
Yungjin Pharm. Co., Ltd's total revenue sank by 5.0% to $51B since the same quarter in the previous year.
Its net income has increased by 19.3% to $-2B since the same quarter in the previous year.
Finally, its free cash flow grew by 190.6% to $5B since the same quarter in the previous year.
Based on the above factors, Yungjin Pharm. Co., Ltd gets an overall score of 3/5.